| NAME |
NIVOLUMAB 12MG/RELATLIMAB-RMBW 4MG/ML INJ,SOLN |
| VA GENERIC NAME |
NIVOLUMAB/RELATLIMAB-RMBW |
| DOSAGE FORM |
INJ,SOLN |
| FDA MED GUIDE |
Nivolumab_Relatlimab-rmbw_(Opdualag)_(2022).pdf |
| HAZARDOUS TO DISPOSE |
NO |
| ACTIVE INGREDIENTS |
|
| CS FEDERAL SCHEDULE |
Unscheduled |
| SINGLE/MULTI SOURCE PRODUCT |
Multisource |
| NATIONAL FORMULARY NAME |
NIVOLUMAB/RELATLIMAB-RMBW INJ,SOLN |
| CREATE DEFAULT POSSIBLE DOSAGE |
NO |
| POSSIBLE DOSAGES TO CREATE |
No Possible Dosages |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 3
- COPAY EFFECTIVE DATE: 2022-04-01 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
NIVOLUMAB12MG/RELATLIMAB-RMBW 4MG/ML INJ |
| VA PRODUCT IDENTIFIER |
N0886 |
| TRANSMIT TO CMOP |
NO |
| VA DISPENSE UNIT |
ML |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4041303 |
| EFFECTIVE DATE/TIME |
-
- 2022-04-04 00:00:00
- STATUS: ACTIVE
|
